<DOC>
	<DOCNO>NCT01854697</DOCNO>
	<brief_summary>This study evaluate efficacy safety three experimental drug compare telaprevir ( licensed product ) people hepatitis C virus infection treatment .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Three Experimental Drugs Compared With Telaprevir ( Licensed Product ) People With Hepatitis C Virus Infection Who Have Not Had Treatment Before</brief_title>
	<detailed_description>The primary purpose study demonstrate treatment ABT-450/ritonavir ( r ) /ABT-267 ABT-333 administer without ribavirin ( RBV ) non-inferior efficacy compare treatment telaprevir pegylated interferon alpha-2a ( pegIFN ) RBV compare safety regimens treatment-naive hepatitis C virus ( HCV ) genotype ( GT ) 1a- 1b-infected adult .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>Males females 18 65 year , inclusive , time Screening Females must postmenopausal 2 year surgically sterile practice abstinence/specific form birth control Subject never receive antiviral treatment hepatitis C infection Chronic HCV Genotype1 infection prior study enrollment Positive test result Hepatitis B surface antigen ( HBsAg ) antiHuman Immunodeficiency virus antibody ( HIV Ab ) Females pregnant plan become pregnant , breastfeed Any current past clinical evidence cirrhosis Screening laboratory analysis show abnormal laboratory result Use contraindicate medication within 2 week dose subject contraindication telaprevir , pegIFN RBV Recent ( within 6 month prior study drug administration ) history drug alcohol abuse could preclude adherence protocol Positive screen drug alcohol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>Interferon Free</keyword>
	<keyword>Hepatitis C Treatment Naive</keyword>
	<keyword>Hepatitis C Virus</keyword>
	<keyword>Hepatitis C Genotype 1</keyword>
</DOC>